# EPB42

## Overview
The EPB42 gene encodes the erythrocyte membrane protein band 4.2, a peripheral membrane protein that plays a critical role in maintaining the structural integrity and functionality of red blood cells. This protein is categorized as a peripheral membrane protein due to its association with the inner surface of the erythrocyte membrane, where it interacts with other membrane proteins such as band 3, ankyrin, spectrin, and CD47. These interactions are essential for the mechanical stability and flexibility of erythrocytes, allowing them to withstand the stresses of circulation. Protein 4.2 is involved in the formation of macromolecular complexes that contribute to the erythrocyte's cytoskeletal network, despite lacking enzymatic activity typically associated with transglutaminases (Satchwell2009Protein; Korsgren2010Protein). Mutations in the EPB42 gene can lead to hereditary spherocytosis, a condition characterized by hemolytic anemia, underscoring the protein's importance in red blood cell physiology (van2010Band). Additionally, alterations in EPB42 expression have been implicated in certain cancers, such as pancreatic adenocarcinoma, suggesting a broader role in cellular processes beyond erythrocytes (Meng2020Mass).

## Structure
Protein 4.2, encoded by the EPB42 gene, is a peripheral membrane protein primarily found in erythrocytes. It is composed of 691 amino acids and exists in two isoforms: a major 72 kDa form and a minor 74 kDa form, resulting from alternative splicing (Satchwell2009Protein). The protein shares sequence homology with transglutaminases but lacks the catalytic triad necessary for enzymatic activity (Satchwell2009Protein). 

Protein 4.2 undergoes post-translational modifications, including myristylation at an N-terminal glycine and palmitoylation on cysteine 203, which may facilitate its interaction with the inner leaflet of the erythrocyte membrane (Satchwell2009Protein). The protein interacts with several other membrane proteins, including the N-terminal cytoplasmic domain of the anion exchanger band 3, ankyrin, spectrin, and CD47, contributing to the structural integrity of the red cell membrane (Satchwell2009Protein; Korsgren2010Protein).

A proposed homology model suggests that protein 4.2 may adopt a structure similar to transglutaminases, facilitating macromolecular complex formation despite lacking enzymatic activity (Satchwell2009Protein). The model indicates that certain regions, such as the B3/ankyrin binding hairpin loop, may require structural flexibility to become accessible (Satchwell2009Protein).

## Function
Protein 4.2, encoded by the EPB42 gene, is a peripheral membrane protein crucial for maintaining the structural integrity and function of erythrocytes. It constitutes about 5% of the erythrocyte membrane and interacts with several key proteins, including the anion exchanger band 3 (B3), ankyrin, spectrin, and CD47 (van2010Band; Satchwell2009Protein). These interactions are essential for the stability and flexibility of red blood cells, contributing to their mechanical properties and survival in circulation (Satchwell2009Protein).

Protein 4.2 stabilizes the band 3-ankyrin-1 association, which is vital for erythrocyte stability and flexibility (van2010Band). It also binds to the EF-domain of α-spectrin in a calcium- and calmodulin-dependent manner, which is crucial for the structural integrity of the red blood cell membrane skeleton (Korsgren2010Protein). The interaction with CD47, a component of the Rh complex, helps anchor this complex to the red cell skeleton and is implicated in preventing the clearance of red cells by macrophages (Satchwell2009Protein).

Deficiency in protein 4.2 is associated with hereditary spherocytosis, a condition characterized by hemolytic anemia, highlighting its importance in erythrocyte function (van2010Band; Satchwell2009Protein).

## Clinical Significance
Mutations in the EPB42 gene, which encodes erythrocyte membrane protein band 4.2, are associated with hereditary spherocytosis (HS), a form of hereditary hemolytic anemia. This condition is characterized by the presence of spherical red blood cells that are prone to destruction, leading to symptoms such as hemolysis, splenomegaly, jaundice, and gallstones (Wang2021Mutational; Vyas2021Insilico). EPB42-related HS is typically mild to moderate in severity and is classified as an autosomal recessive trait (Yamamoto2022Clinical; Chen2016A).

In addition to its role in HS, alterations in EPB42 expression levels have been linked to pancreatic adenocarcinoma (PAAD). Studies have shown that EPB42 is downregulated in PAAD tissues compared to adjacent normal tissues, and this downregulation is associated with poor overall survival in patients, suggesting its potential as a prognostic marker (Meng2020Mass). The differential expression of EPB42 in cancerous tissues highlights its possible involvement in the progression and prognosis of pancreatic cancer (Meng2020Mass).

## Interactions
Protein 4.2, encoded by the EPB42 gene, is a peripheral membrane protein that interacts with several other proteins to maintain erythrocyte membrane stability. It binds to the N-terminal cytoplasmic domain of the anion exchanger Band 3 (B3), although the exact binding site is not precisely known. This interaction is crucial for the presence of protein 4.2 in red blood cells, and mutations in protein 4.2 can affect its binding to B3 (Satchwell2009Protein). Protein 4.2 also interacts with ankyrin, specifically the erythroid form AnkR, which is essential for maintaining erythrocyte integrity. The ankyrin binding domain of protein 4.2 is localized to residues 187-200, near the proposed B3 binding site (Satchwell2009Protein).

Protein 4.2 interacts with CD47, a glycosylated transmembrane protein, which is involved in preventing red blood cell clearance by macrophages. In protein 4.2 deficient cells, CD47 levels decrease significantly (van2010Band; Satchwell2009Protein). Additionally, protein 4.2 interacts with spectrin, a major cytoskeletal protein, through a specific binding domain, supporting its role in cytoskeletal connectivity (Satchwell2009Protein). These interactions highlight the importance of protein 4.2 in maintaining the structural integrity of red blood cells.


## References


[1. (Yamamoto2022Clinical) Keiko Shimojima Yamamoto, Taiju Utshigisawa, Hiromi Ogura, Takako Aoki, Takahiro Kawakami, Shoichi Ohga, Akira Ohara, Etsuro Ito, Toshiyuki Yamamoto, and Hitoshi Kanno. Clinical and genetic diagnosis of thirteen japanese patients with hereditary spherocytosis. Human Genome Variation, January 2022. URL: http://dx.doi.org/10.1038/s41439-021-00179-1, doi:10.1038/s41439-021-00179-1. This article has 9 citations.](https://doi.org/10.1038/s41439-021-00179-1)

[2. (Chen2016A) Jing Chen, Yang Zhou, Yaqi Gao, Weijie Cao, Hui Sun, Yanfang Liu, and Chong Wang. A genetic features and gene interaction study for identifying the genes that cause hereditary spherocytosis. Hematology, 22(4):240–247, October 2016. URL: http://dx.doi.org/10.1080/10245332.2016.1235673, doi:10.1080/10245332.2016.1235673. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/10245332.2016.1235673)

[3. (Meng2020Mass) Mingming Meng, Sanhong Liu, Chen Wang, Xinjin Gu, Enqiang Linghu, and Xinying Xue. Mass spectrum analysis of membrane proteins reveals that cask, cd36 and epb42 are differentially expressed in pancreatic adenocarcinoma. Oncology Letters, 20(6):1–1, October 2020. URL: http://dx.doi.org/10.3892/ol.2020.12239, doi:10.3892/ol.2020.12239. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2020.12239)

[4. (Satchwell2009Protein) Timothy J. Satchwell, Debbie K. Shoemark, Richard B. Sessions, and Ashley M. Toye. Protein 4.2 : a complex linker. Blood Cells, Molecules, and Diseases, 42(3):201–210, May 2009. URL: http://dx.doi.org/10.1016/j.bcmd.2009.01.005, doi:10.1016/j.bcmd.2009.01.005. This article has 44 citations.](https://doi.org/10.1016/j.bcmd.2009.01.005)

[5. (Wang2021Mutational) Dong Wang, Li Song, Li Shen, Kaihui Zhang, Yuqiang Lv, Min Gao, Jian Ma, Ya Wan, Zhongtao Gai, and Yi Liu. Mutational characteristics of causative genes in chinese hereditary spherocytosis patients: a report on fourteen cases and a review of the literature. Frontiers in Pharmacology, July 2021. URL: http://dx.doi.org/10.3389/fphar.2021.644352, doi:10.3389/fphar.2021.644352. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2021.644352)

[6. (van2010Band) Emile van den Akker, Timothy J. Satchwell, Rosalind C. Williamson, and Ashley M. Toye. Band 3 multiprotein complexes in the red cell membrane; of mice and men. Blood Cells, Molecules, and Diseases, 45(1):1–8, June 2010. URL: http://dx.doi.org/10.1016/j.bcmd.2010.02.019, doi:10.1016/j.bcmd.2010.02.019. This article has 71 citations.](https://doi.org/10.1016/j.bcmd.2010.02.019)

7. (Vyas2021Insilico) In-silico analysis of mutations in ANK1, SPTB, SPTA1, SLC4A1, and EPB4.2 genes responsible for Hereditary Spherocytosis. This article has 0 citations.

[8. (Korsgren2010Protein) Catherine Korsgren, Luanne L. Peters, and Samuel E. Lux. Protein 4.2 binds to the carboxyl-terminal ef-hands of erythroid α-spectrin in a calcium- and calmodulin-dependent manner. Journal of Biological Chemistry, 285(7):4757–4770, February 2010. URL: http://dx.doi.org/10.1074/jbc.m109.056200, doi:10.1074/jbc.m109.056200. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m109.056200)